Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenzhen Xinyue Biotechnology
Shenzhen, Guangdong, Chinachemicalbook.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Shenzhen Xinyue Biotechnology provides modular standalone solutions for novel drug discovery, collaborating with biotech/pharma companies and academic institutions. The company has at least one program targeting mitogen activated protein kinase kinase kinase kinase 1, likely at the preclinical or research stage[1][8].
- Industry
- Drug Discovery Services
02
Partnerships
Received funding from XtalPi Holdings
Beyond the preview
Go deeper on Shenzhen Xinyue Biotechnology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shenzhen Xinyue Biotechnology.